The HaPPeN team had a 3-day monitoring visit by the research team from AxoGen a USA based leading peripheral nerve repair medical devices company. The RANGER study is an international multi-centre registry study evaluating the use of AVANCE processed nerve allograft in nerve gap repair and the HaPPeN team have been recruiting to the study since 2018. During the visit the team discussed the developments in set up of the Sensation NOW study evaluating sensory recovery after autologous breast reconstruction which will be delivered through the HaPPeN team in Birmingham.
The HaPPeN team and the UHB breast reconstruction team met at the ITM in Birmingham to discuss the opportunity to collaborate with AxoGen Inc in the multi-centre international Sensation NOW registry study, evaluating outcomes and sensation after autologous breast reconstruction.
The CoNNECT Study is an RCT in suture-less nerve repai supported by a grant from POLYGANICS BV, Netherlands. The study is recruiting digital nerve repairs over three years in Birmingham. In February 2019 the Birmingham Hand Centre team has reached 1/3 recruitment target with 82/240 nerves repaired.
The Protect Neuro Trial is an international multi-centre study evaluating the Neurocap in neuroma pain management. Recruitment at the 23 centres closed in August 2018 and follow-up is ongoing. The HaPPeN team at UHB were the leading recruitment centre with 22/73 cases completed in Birmingham, UK.
the SUBMIT study is evaluating the method of fixation in metacarpal fractures in the hand. The trial rolled out to multi-centre in 2018 and this has helped the team reach their interim recruitment target. A further centre will be initiated in Q1 2019 that should enable full recruitment to be reached by summer 2020.
The HaPPeN team hosted a team from POLYGANICS BV, Netherlands, a polymer technology company that is supporting the CoNNECT study at UHB and sponsoring the Protect NEURO trial. The team presented their latest research and recruitment and retention numbers for the current trials and agreed to work on a feasibility study protocol for a future neuroma prevention trial.
Sign up to hear from us about specials, sales, and events.